U.S., Feb. 4 -- An application to own the trademark for 'TORIX' has been filed on Nov. 24, 2023. Owner(s): JUN SON; (Juan-dong, Myeongju ARDIE) 1108ho,, 27, Michuhol-daero 733beon-gil, Michuhol-gu I... Read More
U.S., Feb. 4 -- An application to own the trademark for 'LINDT' has been filed on Sep. 05, 2023. Owner(s): Chocoladefabriken Lindt & Sprüngli AG; Seestrasse 204, CH-8802 Kilchberg ZH, SWITZERLAND G... Read More
WASHINGTON, Feb. 4 -- Sen. Cory Booker issued the following press release: U.S. Senators Cory Booker (D-NJ), Tim Kaine (D-VA), Adam Schiff (D-CA), Ben Ray Lujan (D-NM), and Mazie Hirono (D-HI) introd... Read More
WASHINGTON, Feb. 4 -- Sen. Lisa Blunt Rochester issued the following press release: U.S. Senator Lisa Blunt Rochester (D-Del.), a member of the Senate Environment and Public Works Committee, today pa... Read More
WASHINGTON, Feb. 4 -- Sen. Richard Blumenthal issued text of the following press release: In case you missed it, U.S. Senator Richard Blumenthal (D-CT), Ranking Member of the Permanent Subcommittee o... Read More
WASHINGTON, Feb. 4 -- Sen. Richard Blumenthal issued text of the following press release: U.S. Senator Richard Blumenthal (D-CT), Ranking Member of the Permanent Subcommittee on Investigations (PSI),... Read More
Washington, Feb. 4 -- Congresswoman Sarah Elfreth issued the following press release: Yesterday, Congresswoman Sarah Elfreth (MD-03) spoke on the House floor during a Special Order Hour organized by ... Read More
Geneva, Feb. 13 -- International Clinical Trials Registry received information related to the study (NCT07388537) titled 'Evaluation of the Clinical Spectrum of Diabetes and Obesity in Youth and Adult... Read More
Geneva, Feb. 13 -- International Clinical Trials Registry received information related to the study (NCT07388524) titled 'Testing the Impact of an Anti-Cancer Drug, Atezolizumab, After Surgery to Prev... Read More
Geneva, Feb. 13 -- International Clinical Trials Registry received information related to the study (NCT07388563) titled 'Azacitidine and Abatacept in Relapsed or Refractory T-Cell Lymphoma' on Feb. 4... Read More